The US Food and Drug Administration has approved a number of vaccines for the 2010-11 influenza season.
The vaccine has been designed to protect against three strains including the 2009 H1N1 influenza virus, unlike last year where two separate vaccines were required to treat the pandemic.
Manufacturers of the vaccine include Afluria, CSL, Agriflu, Novartis Vaccines and Diagnostics, GlaxoSmithKline Biologicals and Fluvirin, among others.
The 2010-11 seasonal influenza vaccines contain the following strains: A/California/7/09 (H1N1)-like virus (pandemic (H1N1) 2009 influenza virus), A/Perth /16/2009 (H3N2)-like virus and the B/Brisbane/60/2008-like virus.
The labelling for CSL’s Afluria vaccine has undergone changes, informing health care providers of increased evidence of fever and febrile seizure in young children following administration of the 2010 Southern Hemisphere formulation of the vaccine.